Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
19 Mar - 12 Apr 2016
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
Adopted in 2001
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Department of Science and Technology, Government of India
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
446-630-3
EC Name:
-
Cas Number:
181587-01-9
Molecular formula:
C13H9Cl2F3N4OS
IUPAC Name:
5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(ethanesulfinyl)-1H-pyrazole-3-carbonitrile

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Intox PVT. Ltd.
- Females nulliparous and non-pregnant: yes
- Age at start of treatment: 8 weeks
- Body weight at start of treatment: 145 - 155 g (females)
- Fasting period before study: Yes, rats were fasted overnight prior to dosing. Food was offered 3 - 4 h after dosing.
- Housing: group housing, 3 animals of the same dose group in one cage (cage size: 35 cm (L) x 22 cm (W) x 18 cm (H)), in sterilized solid bottom polypropylene cages with stainless steel grill tops and sterilized paddy husk bedding
- Diet: extruded pelleted rat feed Altromin (manufactured by M/s Altromin Spezialfutter GmbH & Co. KG, Germany, and supplied by ATNT Laboratories, Mumbai, India), ad libitum
- Water: filtered water of drinking water quality, ad libitum
- Acclimation period: 7 - 10 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23
- Humidity (%): 38 - 66
- Air changes (per hr): 11.03 - 14.6
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 19 Mar 2016 To: 12 Apr 2016

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: analytical grade water with 0.2% Tween 80
Details on oral exposure:
VEHICLE
- Test substance concentration in vehicle: 200 mg/mL
- Amount of vehicle: 10 mL/kg bw

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw

DOSAGE PREPARATION: Formulations of the test substance were prepared freshly before dosing on each day. The test substance was suspended in analytical grade water with 0.2% Tween 80 as a wetting agent.

CLASS METHOD
- Rationale for the selection of the starting dose: A previous acute toxicity study revealed that the oral LD50 value in male and female rats is >7080 mg/kg bw. Based on the available information, the present study was started at the dose level of 2000 mg/kg bw, according to OECD TG 423.


Doses:
2000 mg/kg bw (step 1 and step 2)
No. of animals per sex per dose:
3 female animals per group; two groups were tested stepwise in 2 consecutively steps (referred as step 1 and step 2)
Control animals:
no
Remarks:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for mortality twice a day throughout the observation period. Following test substance administration, animals were observed for clinical signs of toxicity 10 min, 30 min, 1 h, 2 h and 4 h post dosing and periodically thereafter for the first 24 h post dosing. During the 14-day observation period, animals were observed at least once a day. Body weight was measured at one day prior to dosing (Day 0), on the day of dosing (Day 1, fasting body weight), on Day 7 and at study termination on Day 15.
- Necropsy of survivors performed: yes
Statistics:
Body weight gain and group mean values were calculated.

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
female
Dose descriptor:
LD0
Effect level:
2 000 mg/kg bw
Based on:
test mat.
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Remarks on result:
not determinable due to absence of adverse toxic effects
Mortality:
No mortality occurred during the study period.
Clinical signs:
other: No clinical signs of toxicity were observed up to the end of the 14-day observation period.
Gross pathology:
Necropsy revealed no substance-related findings.

Any other information on results incl. tables

Table 1. Acute oral toxicity

 

Dose

[mg/kg bw]

Mortality

Clinical signs

 

N*

N*

Females

2000

0/6

0/6

*N = number of animals/ number of animals used (shown as combined values from step 1 and step 2)

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
Conclusions:
In the present acute oral toxicity study in rats no mortality (0/6 rats) occured after single gavage of 2000 mg/kg bw of the test substance.
CLP: not classified